Home

filósofo ensillar patrocinado cholangiocarcinoma ca 19 9 cea index of marker Rebaja El otro día reloj

CA19-9 for detecting recurrence of pancreatic cancer | Scientific Reports
CA19-9 for detecting recurrence of pancreatic cancer | Scientific Reports

CEA but not CA19-9 is an independent prognostic factor in patients  undergoing resection of cholangiocarcinoma. - Abstract - Europe PMC
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma. - Abstract - Europe PMC

PDF] State of serum markers for detection of cholangiocarcinoma. | Semantic  Scholar
PDF] State of serum markers for detection of cholangiocarcinoma. | Semantic Scholar

Cancers | Free Full-Text | Prognostic and Predictive Molecular Markers in  Cholangiocarcinoma
Cancers | Free Full-Text | Prognostic and Predictive Molecular Markers in Cholangiocarcinoma

The power to predict with biomarkers: carbohydrate antigen 19-9 (CA 19-9)  and carcinoembryonic antigen (CEA) serum markers in intrahepatic  cholangiocarcinoma - Jaklitsch - Translational Gastroenterology and  Hepatology
The power to predict with biomarkers: carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA) serum markers in intrahepatic cholangiocarcinoma - Jaklitsch - Translational Gastroenterology and Hepatology

CEA but not CA19-9 is an independent prognostic factor in patients  undergoing resection of cholangiocarcinoma | Scientific Reports
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports

Preoperative CEA levels are supplementary to CA19-9 levels in predicting  prognosis in patients with resectable intrahepatic cholangiocarcinoma
Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma

PDF) CA 242, a new tumour marker for pancreatic cancer: A comparison with CA  19-9, CA 50 and CEA
PDF) CA 242, a new tumour marker for pancreatic cancer: A comparison with CA 19-9, CA 50 and CEA

CEA but not CA19-9 is an independent prognostic factor in patients  undergoing resection of cholangiocarcinoma | Scientific Reports
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports

Tumor marker analysis in the cases with and without cholangiocarcinoma |  Download Table
Tumor marker analysis in the cases with and without cholangiocarcinoma | Download Table

The power to predict with biomarkers: carbohydrate antigen 19-9 (CA 19-9)  and carcinoembryonic antigen (CEA) serum markers in intrahepatic  cholangiocarcinoma - Jaklitsch - Translational Gastroenterology and  Hepatology
The power to predict with biomarkers: carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA) serum markers in intrahepatic cholangiocarcinoma - Jaklitsch - Translational Gastroenterology and Hepatology

Preoperative CEA levels are supplementary to CA19-9 levels in predicting  prognosis in patients with resectable intrahepatic cholangiocarcinoma
Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma

Prognostic factors for operable biliary tract cancer: serum levels of | OTT
Prognostic factors for operable biliary tract cancer: serum levels of | OTT

Preoperative CEA levels are supplementary to CA19-9 levels in predicting  prognosis in patients with resectable intrahepatic cholangiocarcinoma
Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma

Univariate analysis of CA 19-9 and CEA as a categorical variable | Download  Table
Univariate analysis of CA 19-9 and CEA as a categorical variable | Download Table

CEA but not CA19-9 is an independent prognostic factor in patients  undergoing resection of cholangiocarcinoma | Scientific Reports
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports

CEA but not CA19-9 is an independent prognostic factor in patients  undergoing resection of cholangiocarcinoma | Scientific Reports
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports

Preoperative CEA levels are supplementary to CA19-9 levels in predicting  prognosis in patients with resectable intrahepatic cholangiocarcinoma
Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma

The diagnostic value of five serum tumor markers for patients with  cholangiocarcinoma - ScienceDirect
The diagnostic value of five serum tumor markers for patients with cholangiocarcinoma - ScienceDirect

CA 19-9 as a Marker of Survival and a Predictor of Metastization in  Cholangiocarcinoma - FullText - GE - Portuguese Journal of Gastroenterology  2017, Vol. 24, No. 3 - Karger Publishers
CA 19-9 as a Marker of Survival and a Predictor of Metastization in Cholangiocarcinoma - FullText - GE - Portuguese Journal of Gastroenterology 2017, Vol. 24, No. 3 - Karger Publishers

CEA but not CA19-9 is an independent prognostic factor in patients  undergoing resection of cholangiocarcinoma | Scientific Reports
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports

Survival prediction for patients with non-resectable intrahepatic  cholangiocarcinoma undergoing chemotherapy: a retrospective analysis  comparing the tumor marker CA 19-9 with cross-sectional imaging |  SpringerLink
Survival prediction for patients with non-resectable intrahepatic cholangiocarcinoma undergoing chemotherapy: a retrospective analysis comparing the tumor marker CA 19-9 with cross-sectional imaging | SpringerLink

Gene Variants That Affect Levels of Circulating Tumor Markers Increase  Identification of Patients With Pancreatic Cancer - ScienceDirect
Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer - ScienceDirect

Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer
Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer

Common benign HPB conditions with associated deranged CA19.9 level |  Download Table
Common benign HPB conditions with associated deranged CA19.9 level | Download Table